STP
WGS icon

Science & Technology Partners’s GeneDx Holdings WGS Stock Holding History

Science & Technology Partners’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.3M Sell
106,387
-134,813
-56% -$7.66M 1.23% 27
2026
Q1 		$15.5M Buy
241,200
+39,936
+20% +$3.64M 4.05% 11
2025
Q4 		$26.2M Sell
201,264
-22,809
-10% -$3.13M 7.28% 2
2025
Q3 		$24.1M Sell
224,073
-93,203
-29% -$10.2M 6.73% 3
2025
Q2 		$29.3M Buy
317,276
+40,635
+15% +$3.19M 7.67% 2
2025
Q1 		$24.5M Sell
276,641
-124,359
-31% -$10.8M 9.71% 1
2024
Q4 		$30.8M Buy
+401,000
New +$28M 9.36% 1

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Science & Technology Partners's WGS Position: Q2 2026 in Review

Science & Technology Partners reduced its GeneDx Holdings (WGS) stake by 56% in Q2 2026, selling an estimated $7.66M and leaving 106,387 shares worth $7.3M. The position accounts for 1.23% of the portfolio, ranked #27.

Science & Technology Partners first reported a position in WGS in Q4 2024 and has held it in 7 quarters since. The position peaked at $30.8M in Q4 2024. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Science & Technology Partners held 106,387 shares of GeneDx Holdings worth $7.3M as of Q2 2026.
  • Science & Technology Partners sold 134,813 GeneDx Holdings shares in Q2 2026, an estimated $7.66M.
  • GeneDx Holdings made up 1.23% of Science & Technology Partners's portfolio in Q2 2026, its #27 holding.
  • Science & Technology Partners first reported a position in GeneDx Holdings in Q4 2024 and has held it in 7 quarters since.
  • Science & Technology Partners's GeneDx Holdings position peaked at $30.8M in Q4 2024.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Science & Technology Partners's 13F filing for Q2 2026, filed 14 Aug 2026.